highlight / actuality
We demonstrate the value of using a cocktail of protein kinase inhibitors against a form of kidney cancer. For this, they assessed the impact of combinations of molecules on the viability of kidney cancer cells grown as spheroids, or organ cultures of tumors. The synergistic benefit of two molecules allowed to file a patent.
Thesis presented July 15, 2021 by Farah Kobaisi.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.